Vyepti concentrate for solution for infusion 100 mg (300 mg not marketed)

Company:
Lundbeck (Ireland) Limited
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Eptinezumab
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/21/1599/001

100 mg

N02CD05

Concentrate for solution for infusion

EU/1/21/1599/002

100 mg

N02CD05

Concentrate for solution for infusion

EU/1/21/1599/003

300 mg

N02CD05

Concentrate for solution for infusion